A. Sorana

Oct 10, 2024 | genomebiology.biomedcentral.com | Ngoc Hà |Ngọc Hà |A. Sorana |Varsha Thoppey

Xenograft samples were generated from brain tumor-initiating cells (BTICs) established from patients with primary and recurrent GBM [30] surgical material available through our institution’s Clark Smith Tumor Biobank. Lines were maintained as previously described [31] prior to intracranial implantation into 6- to 8-week-old female SCID mice [7, 71].